BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10292532)

  • 1. Financial evaluation of HMOs and PPOs.
    Goldman RL; Shoen CB; Kopp WC
    Health Mark Q; 1988; 5(3-4):89-100. PubMed ID: 10292532
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-unit providers survey--HMOs/PPOs. Managed-care growth continued in 1987 despite companies' poor operating results.
    Kenkel PJ
    Mod Healthc; 1988 Jun; 18(23):20-4, 28-34, 38. PubMed ID: 10287291
    [No Abstract]   [Full Text] [Related]  

  • 3. HMOs and PPOs: similarities and differences.
    Dalton JJ
    Top Health Care Financ; 1987; 13(3):8-18. PubMed ID: 3564012
    [No Abstract]   [Full Text] [Related]  

  • 4. When is it time to walk away from an HMO/PPO contract? How to analyze the financial impact of alternative delivery systems on hospitals.
    Turner BN; Valentine ST
    Healthc Forum J; 1989; 32(2):13-6. PubMed ID: 10292195
    [No Abstract]   [Full Text] [Related]  

  • 5. Identifying incremental cost in HMO/PPO bid evaluation.
    Annis RJ; Holton JW
    Health Prog; 1986 Apr; 67(3):26-8. PubMed ID: 10275904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMOs are reduced to being prepaid indemnity health insurers.
    Johnson DE
    Health Care Strateg Manage; 2001 Jun; 19(6):19, 1. PubMed ID: 11409094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nursing PPOs for corporate clients.
    Collins BA
    Nurs Econ; 1987; 5(2):86-9. PubMed ID: 3645313
    [No Abstract]   [Full Text] [Related]  

  • 8. The union experience with health maintenance organizations and preferred provider organizations.
    Sigelbaum HC
    Bull N Y Acad Med; 1987; 63(1):42-8. PubMed ID: 3470096
    [No Abstract]   [Full Text] [Related]  

  • 9. HMOs and PPOs: an operational guide.
    Arnold WV; Leonard MA
    Top Health Care Financ; 1987; 13(3):19-31. PubMed ID: 3564010
    [No Abstract]   [Full Text] [Related]  

  • 10. Marketing home care to HMOs/PPOs: results of a national survey.
    Louden TL
    Caring; 1986 Jul; 5(7):65-7. PubMed ID: 10278843
    [No Abstract]   [Full Text] [Related]  

  • 11. Control costs through contract examination.
    Tintari M; Greenberg N; Pishko L
    Patient Acc; 1986 Oct; 9(10):2. PubMed ID: 10278727
    [No Abstract]   [Full Text] [Related]  

  • 12. HMOs remain a riskier proposition than PPOs.
    Manag Care; 1994 Mar; 3(3):12. PubMed ID: 10140025
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative delivery systems of health care.
    Baer RK
    Top Health Care Financ; 1985; 12(1):56-63. PubMed ID: 4049382
    [No Abstract]   [Full Text] [Related]  

  • 14. HMOs: the financial picture.
    Personnel; 1981; 58(6):56-8. PubMed ID: 10253933
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of injecting price competition into the hospital market: the case of preferred provider organizations.
    Dranove D; Satterthwaite M; Sindelar J
    Inquiry; 1986; 23(4):419-31. PubMed ID: 2947862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asking the right questions in HMO and PPO evaluation.
    Millikan DL
    Healthc Financ Manage; 1986 May; 40(5):38-41. PubMed ID: 10300703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congressman Wyden hails new players as impetus to competitive health care.
    Wyden R
    Rev Fed Am Hosp; 1986; 19(1):30-1. PubMed ID: 10275824
    [No Abstract]   [Full Text] [Related]  

  • 18. When used, managed care is costly.
    McLaughlin N
    Mod Healthc; 1987 Mar; 17(7):52. PubMed ID: 10281058
    [No Abstract]   [Full Text] [Related]  

  • 19. The hidden costs of contracting with managed care plans.
    King MM; Topping TT
    Trustee; 1987 Jun; 40(6):27-30. PubMed ID: 10282486
    [No Abstract]   [Full Text] [Related]  

  • 20. PPOs delivery what HMOs don't. PPOs blossom as consumers demand choice, access, and affordability.
    Kalish B
    Mod Healthc; 1998 Apr; 28(16):96. PubMed ID: 10179151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.